FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
6 articles
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
A landmark study published in Neurology, the medical journal of the American Academy of Neurology, has found that women who used estrogen-only menopausal hormone therapy...
WHO Releases Updated Guidelines: Up to 45% of Dementia Risk Can Be Prevented or Delayed The World Health Organization (WHO) has released updated guidelines on...
WHO Issues New Recommendations for Reducing Cognitive Decline The World Health Organization (WHO) has released updated guidelines on reducing the risk of cognitive decline and...
WHO Unveils Updated Guidelines to Combat Rising Dementia Rates Worldwide The World Health Organization (WHO) has officially launched the second edition of its Guidelines on...
A groundbreaking study from the University of California, Riverside has proposed a new explanation for how Alzheimer’s disease may begin, potentially reshaping decades of scientific...